We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$10.7B
AUM Growth
-$1.2B
Cap. Flow
-$1.77B
Cap. Flow %
-16.59%
Top 10 Hldgs %
17.61%
Holding
1,734
New
553
Increased
270
Reduced
235
Closed
408

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$107M
2
STX icon
Seagate
STX
+$46.6M
3
ROP icon
Roper Technologies
ROP
+$46.2M
4
INTC icon
Intel
INTC
+$44.7M
5
NTNX icon
Nutanix
NTNX
+$42.7M

Sector Composition

Rank Sector Weight
1 Technology 10.53%
2 Financials 5.9%
3 Healthcare 3.32%
4 Energy 2.62%
5 Communication Services 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBYDW icon
1151
Falcon's Beyond Global Warrants
FBYDW
$16M
$51K ﹤0.01%
50,993
+993
+2% +$771
SEER icon
1152
Seer Inc
SEER
$108M
$50.5K ﹤0.01%
+29,908
New +$65.1K
LFT
1153
Lument Finance Trust
LFT
$41.2M
$50.2K ﹤0.01%
+19,232
New +$51.5K
KRMD icon
1154
KORU Medical Systems
KRMD
$187M
$49K ﹤0.01%
+19,306
New +$71.7K
AIRJ
1155
Montana Technologies Corp
AIRJ
$313M
$46.9K ﹤0.01%
+10,169
New +$79.4K
UHGWW
1156
DELISTED
United Homes Group Warrant
UHGWW
$46.7K ﹤0.01%
73,510
MO icon
1157
Altria Group
MO
$122B
$46.3K ﹤0.01%
772
+767
+15,340% +$41.9K
TOIIW
1158
The Oncology Institute Warrant
TOIIW
$44K ﹤0.01%
1,624,856
LSBPW
1159
DELISTED
LakeShore Biopharma Warrants
LSBPW
$43.4K ﹤0.01%
1,052,461
LOTWW
1160
Lotus Technology Inc Warrants
LOTWW
$41.9K ﹤0.01%
343,010
NWS icon
1161
News Corp Class B
NWS
$16.8B
$41.8K ﹤0.01%
+1,377
New +$43.6K
PLMKW
1162
Plum Acquisition Corp IV Warrants
PLMKW
$3.88M
$41.2K ﹤0.01%
+250,000
New +$40K
FE icon
1163
FirstEnergy
FE
$28.5B
$40.4K ﹤0.01%
999
+984
+6,560% +$39.2K
VLN.WS icon
1164
Valens Semiconductor Ltd Warrants
VLN.WS
$40.2K ﹤0.01%
892,096
+45,238
+5% +$3K
LVROW
1165
DELISTED
Lavoro Ltd Warrant
LVROW
$39.6K ﹤0.01%
514,051
ANVS icon
1166
PUT
Annovis Bio
ANVS
$71M
$38K ﹤0.01%
25,300
-4,400
-15% -$13.5K
GWH.WS
1167
DELISTED
ESS Tech Inc Warrant
GWH.WS
$36.2K ﹤0.01%
451,284
EUDAW icon
1168
EUDA Health Holdings Warrant
EUDAW
$218K
$36K ﹤0.01%
300,000
PCG icon
1169
PUT
PG&E
PCG
$47.2B
$34.4K ﹤0.01%
2,000
-168,200
-99% -$2.79M
SVIIR
1170
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$34K ﹤0.01%
350,000
PIIIW icon
1171
P3 Health Partners Inc Warrant
PIIIW
$137K
$30.6K ﹤0.01%
2,546,924
BKR icon
1172
Baker Hughes
BKR
$60.1B
$30.4K ﹤0.01%
+691
New +$30.8K
FLNA
1173
PUT
Filana Therapeutics
FLNA
$43.5M
$30K ﹤0.01%
20,000
-475,400
-96% -$1.2M
TALKW
1174
DELISTED
Talkspace Inc Warrant
TALKW
$29.9K ﹤0.01%
328,366
+250,000
+319% +$35.5K
LEGT.WS
1175
DELISTED
Legato Merger Corp III Warrants
LEGT.WS
$28.9K ﹤0.01%
150,000

Similar funds

LMR Partners's Q1 2025 Portfolio in Review

As of Q1 2025, LMR Partners held 1,734 positions worth $10.7B, down 10% from $11.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

LMR Partners withdrew a net $1.77B in Q1 2025, closing 408 positions and reducing 235 holdings. Its most notable exit was Endeavor Group Holdings, Inc., an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Roper Technologies worth $48.6M.

  • LMR Partners's largest Q1 2025 buy was Roper Technologies: 82,349 shares worth $48.6M.
  • LMR Partners added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $107M increase.
  • LMR Partners's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $469M.
  • LMR Partners fully exited Endeavor Group Holdings, Inc. in Q1 2025, selling an estimated $204M.
  • LMR Partners's ten largest holdings make up 18% of its $10.7B portfolio in Q1 2025.
  • LMR Partners opened 553 new positions and closed 408 in Q1 2025.
  • LMR Partners's portfolio value fell 10% quarter-over-quarter to $10.7B.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.